Fumio Kanda

2.1k total citations
95 papers, 1.4k citations indexed

About

Fumio Kanda is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Fumio Kanda has authored 95 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 26 papers in Cellular and Molecular Neuroscience and 20 papers in Neurology. Recurrent topics in Fumio Kanda's work include Genetic Neurodegenerative Diseases (18 papers), Mitochondrial Function and Pathology (15 papers) and Parkinson's Disease Mechanisms and Treatments (8 papers). Fumio Kanda is often cited by papers focused on Genetic Neurodegenerative Diseases (18 papers), Mitochondrial Function and Pathology (15 papers) and Parkinson's Disease Mechanisms and Treatments (8 papers). Fumio Kanda collaborates with scholars based in Japan, Netherlands and India. Fumio Kanda's co-authors include Kazuo Chihara, Shiho Okuda, Tatsushi Toda, Kenji Jinnai, Kenji Sekiguchi, Hirotoshi Hamaguchi, Hisatomo Kowa, Shigehisa Mitake, Tatsuo Matsushita and Hiroyuki Ishihara and has published in prestigious journals such as Neurology, Kidney International and Human Molecular Genetics.

In The Last Decade

Fumio Kanda

93 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fumio Kanda Japan 21 545 401 335 187 178 95 1.4k
A. Laquérrière France 23 590 1.1× 336 0.8× 271 0.8× 145 0.8× 344 1.9× 77 1.5k
Amilton Antunes Barreira Brazil 25 481 0.9× 339 0.8× 512 1.5× 145 0.8× 186 1.0× 93 1.9k
Francesco Nicita Italy 23 412 0.8× 244 0.6× 239 0.7× 96 0.5× 142 0.8× 94 1.3k
Oren Tomkins‐Netzer United Kingdom 29 484 0.9× 560 1.4× 369 1.1× 220 1.2× 272 1.5× 94 3.2k
Ivana Novaković Serbia 22 573 1.1× 292 0.7× 286 0.9× 69 0.4× 157 0.9× 146 1.4k
John F Doran United Kingdom 7 439 0.8× 369 0.9× 222 0.7× 185 1.0× 229 1.3× 8 1.2k
Michael A. Nigro United States 21 618 1.1× 214 0.5× 221 0.7× 102 0.5× 126 0.7× 36 1.4k
Florian Stögbauer Germany 25 410 0.8× 377 0.9× 525 1.6× 142 0.8× 125 0.7× 69 1.8k
Angela Berardinelli Italy 22 1.2k 2.1× 333 0.8× 273 0.8× 58 0.3× 279 1.6× 70 1.8k
Henry S. Schutta United States 21 400 0.7× 235 0.6× 519 1.5× 120 0.6× 241 1.4× 56 1.4k

Countries citing papers authored by Fumio Kanda

Since Specialization
Citations

This map shows the geographic impact of Fumio Kanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumio Kanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumio Kanda more than expected).

Fields of papers citing papers by Fumio Kanda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumio Kanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumio Kanda. The network helps show where Fumio Kanda may publish in the future.

Co-authorship network of co-authors of Fumio Kanda

This figure shows the co-authorship network connecting the top 25 collaborators of Fumio Kanda. A scholar is included among the top collaborators of Fumio Kanda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumio Kanda. Fumio Kanda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Endo, Hironobu, Takeshi Uenaka, Wataru Satake, et al.. (2017). Japanese WDR45 de novo mutation diagnosed by exome analysis: A case report. Neurology and Clinical Neuroscience. 5(4). 131–133. 1 indexed citations
3.
Sekiguchi, Kenji, et al.. (2017). Ultrasonographic findings of proximal median neuropathy: A case series of suspected distal neuralgic amyotrophy. Journal of the Neurological Sciences. 377. 1–5. 14 indexed citations
4.
Washida, Kazuo, Masafumi Ihara, Hisatsugu Tachibana, et al.. (2014). Association of the ASCO Classification with the Executive Function Subscores of the Montreal Cognitive Assessment in Patients with Postischemic Stroke. Journal of Stroke and Cerebrovascular Diseases. 23(9). 2250–2255. 5 indexed citations
5.
Okuda, Shiho, et al.. (2012). Delayed posthypoxic leukoencephalopathy: Case reports. Rinsho Shinkeigaku. 52(9). 672–676. 10 indexed citations
6.
Okuda, Shiho, et al.. (2011). Clinical Features of Late-onset Poststroke Seizures. Journal of Stroke and Cerebrovascular Diseases. 21(7). 583–586. 30 indexed citations
7.
Kuga, Atsushi, Yutaka Ohsawa, Tadashi Okada, et al.. (2011). Endoplasmic reticulum stress response in P104L mutant caveolin-3 transgenic mice. Human Molecular Genetics. 20(15). 2975–2983. 12 indexed citations
8.
Kaji, Hiroshi, Yasuo Kuroki, Yohko Murakawa, et al.. (2009). Effect of alendronate on bone metabolic indices and bone mineral density in patients treated with high-dose glucocorticoid: a prospective study. Osteoporosis International. 21(9). 1565–1571. 12 indexed citations
9.
Koide, Yukio, Hideki Ishihara, & Fumio Kanda. (2007). Nodular‐type muscle sarcoidosis developing after a dog bite. Muscle & Nerve. 37(2). 262–264. 2 indexed citations
10.
Sekiguchi, Kenji, Fumio Kanda, Kenichi Oishi, et al.. (2004). HLA typing in focal myositis. Journal of the Neurological Sciences. 227(1). 21–25. 15 indexed citations
11.
Masaki, Taro, Atsushi Fukunaga, Mikiko Tohyama, et al.. (2003). Human Herpes Virus 6 Encephalitis in Allopurinol-induced Hypersensitivity Syndrome. Acta Dermato Venereologica. 83(2). 128–131. 32 indexed citations
12.
Yoshihara, Tsuyoshi, et al.. (2001). A novel missense mutation in the early growth response 2 gene associated with late-onset Charcot–Marie–Tooth disease type 1. Journal of the Neurological Sciences. 184(2). 149–153. 29 indexed citations
13.
Kimura, Ken‐ichi, Fumio Kanda, Shiho Okuda, & Kazuo Chihara. (2001). Insulin-like growth factor 1 inhibits glucocorticoid-induced glutamine synthetase activity in cultured L6 rat skeletal muscle cells. Neuroscience Letters. 302(2-3). 154–156. 10 indexed citations
14.
Okubo, Minoru, Fumio Kanda, Keiichi Takahashi, et al.. (1999). Glycogen storage disease type IIIa: first report of a causative missense mutation (G1448R) of the glycogen debranching enzyme gene found in a homozygous patient. Human Mutation. 14(6). 542–543. 13 indexed citations
15.
Kanda, Fumio, et al.. (1999). Preventive effects of insulinlike growth factor-I on steroid-induced muscle atrophy. Muscle & Nerve. 22(2). 213–217. 48 indexed citations
16.
Fukuoka, Yoshihiro, et al.. (1995). [A case of hereditary pressure-sensitive neuropathy, confirmed by a gene analysis].. PubMed. 35(6). 657–60. 3 indexed citations
17.
Ono, S., Fumio Kanda, Keiichi Takahashi, et al.. (1995). Neuronal cell loss in the dorsal raphe nucleus and the superior central nucleus in myotonic dystrophy: a clinicopathological correlation. Acta Neuropathologica. 89(2). 122–125. 11 indexed citations
18.
Jinnai, Kenji, Hiroyuki Yamada, Fumio Kanda, et al.. (1990). A Case of Mitochondrial Myopathy, Encephalopathy and Lactic Acidosis due to Cytochrome <i>c </i>Oxidase Deficiency with Neurogenic Muscular Changes. European Neurology. 30(1). 56–60. 11 indexed citations
19.
Jinnai, Kenji, Kazuo Chihara, Fumio Kanda, Kazuo Tada, & Toshiro Fujita. (1989). Calcitonin gene-related peptide enhances spontaneous acetylcholine release from the rat motor nerve terminal. Neuroscience Letters. 103(1). 64–68. 22 indexed citations
20.
Ono, S., K Inoue, T Mannen, et al.. (1989). Intracytoplasmic inclusion bodies of the thalamus and the substantia nigra, and Marinesco bodies in myotonic dystrophy: a quantitative morphological study. Acta Neuropathologica. 77(4). 350–356. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Laquérrière Breakdown of academic impact, for papers by Amilton Antunes Barreira Breakdown of academic impact, for papers by Francesco Nicita Breakdown of academic impact, for papers by Oren Tomkins‐Netzer Breakdown of academic impact, for papers by Ivana Novaković Breakdown of academic impact, for papers by John F Doran Breakdown of academic impact, for papers by Michael A. Nigro Breakdown of academic impact, for papers by Florian Stögbauer Breakdown of academic impact, for papers by Angela Berardinelli Breakdown of academic impact, for papers by Henry S. Schutta
Rankless by CCL
2026